W21088 - Point of Care Tests Purchasing Announcement

The Massachusetts Department of Public Health (DPH) is seeking expedited collective purchasing for COVID point-of-care tests due to the public health emergency. Through a federal contract with Abbott Diagnostics Scarborough, Inc., the state will be able to purchase the Abbott BinaxNOW rapid antigen test through the Federal Supply Schedule (FSS) program. Massachusetts has been allocated 166,080 tests per month and 4,152 control kits per month, with this allocation ending in mid-January. The federal contract eliminates the need for states to negotiate individual purchasing contracts and provides a consistent source of the BinaxNOW test. The maximum number of tests that states can purchase each month is predetermined based on population to ensure supply availability. The Department of Health and Human Services (DHHS) has provided notice that each state will be able to purchase COVID point-of-care diagnostic tests through this streamlined process, which launched on January 4, 2021 and will remain active at least through September, with the potential to include other tests in the coming months.

This opportunity is open to all states, territories, and other government agencies. There are no set-aside designations or restrictions on the types of organizations that can respond. No incumbent vendors or current contractors are listed, and the opportunity does not mention any existing infrastructure or technology that requires integration. The pricing and other specific details of the federal contract with Abbott Diagnostics Scarborough, Inc. are not provided in the available documents, so the possible award values or budget ranges are unclear.